Form 4 for ADMA ADMA BIOLOGICS, INC.
Accepted 2023-08-30 00:00:00 ET · period of report 2023-08-30 · accession 0001140361-23-041848 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-08-30 | 2023-08-30 | ADMA | Grossman Jerrold B | Dir | P - Purchase | $3.71 | +130.0K | 443.3K | +41% | +$482.3K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-08-30 | P | A | 130,000 | $3.71 | 443,265 | D | — | — | (F1) Reflects the weighted average price of purchases on August 30, 2023. The shares were purchased in multiple transactions ranging from $3.70 to $3.71, inclusive. (F2) Includes, as of the transaction date, (i) 25,815 RSUs granted on March 6, 2023 that will vest in two equal installments, on the six- and 12-month anniversaries of the grant date, becoming fully vested on the one-year anniversary of the grant date, subject to the reporting person's continued service as of the applicable vesting date; and (ii) 417,450 shares of common stock owned by the reporting person. |